InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by McMurdo Matthew Charles. Director active across 3 companies, notably Titan Pharmaceuticals INC. Aggregated, 6 disclosures have been logged. Activity tracked since 26 July 2023. The latest transaction was filed on 25 October 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations